Clobetasol Propionate
Brand name: Clobetasol Propionate
Rank #250 of 500 drugs by total cost
$51.2M
Total Cost
758,575
Total Claims
$51.2M
Total Cost
19,226
Prescribers
$67
Cost per Claim
365,596
Beneficiaries
816,495
30-Day Fills
$2,663
Avg Cost/Provider
39
Avg Claims/Provider
About Clobetasol Propionate
Clobetasol Propionate (sold as Clobetasol Propionate) was prescribed 758,575 times by 19,226 Medicare Part D providers in 2023, costing the program $51.2M. At $67 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 247 | Ranolazine (Ranolazine Er) | $51.6M | 381,631 |
| 248 | Epoetin Alfa (Epogen) | $51.4M | 34,952 |
| 249 | Nifedipine (Nifedipine Er) | $51.2M | 1,249,866 |
| 250 | Clobetasol Propionate (Clobetasol Propionate) | $51.2M | 758,575 |
| 251 | Sodium,calcium,mag,pot Oxybate (Xywav) | $51.1M | 3,234 |
| 252 | Eslicarbazepine Acetate (Aptiom) | $51.1M | 31,472 |
| 253 | Risdiplam (Evrysdi) | $51.1M | 1,891 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology